BPA Call W81K0020A0003-W81K0025FA011
Award Date
1/30/25
Potential Completion Date
9/30/25
Potential Value
$113K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Health Agency (DHA) to Nephron Sterile Compounding Center LLC, a self-certified small disadvantaged business and woman-owned limited liability company. The contract, valued at $37,586.64, is for the provision of various pharmaceutical products and supplies, including specific medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for Injection, and Buffered Lidocaine Buffer in...
This firm fixed price purchase order for $7,902 awards Nephron Sterile Compounding Center LLC to provide various pharmacy supplies under a Blanket Purchase Agreement with the Department of Health and Human Services Indian Health Service through February 2024. The BPA facilitates recurring procurement of supplies to support the agency's pharmacy programs. No set-aside designation applies to this award made to the woman-owned small business for products including medications like Phenylephrine HCI...
This firm fixed price purchase order for $3,450 was awarded by the Department of Health and Human Services Indian Health Service to Nephron Sterile Compounding Center LLC. The award is associated with a Blanket Purchase Agreement to provide pharmaceutical supplies, including specific medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for Injection, and Buffered Lidocaine Buffer in Sodium Bicarbonate. Nephron S.C Inc. will...
This is a $57,600 firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services (HHS), to Nephron Sterile Compounding Center LLC, a small disadvantaged business. The contract is for a Blanket Purchase Agreement (BPA) to provide pharmaceutical products and supplies, including medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call award made by the Defense Health Agency (DHA) to The Compounding Center Inc., a minority-owned, small disadvantaged business. The $400,000 award is for the delivery of specialized pharmaceuticals and compounded medications to address drug shortages impacting patient care at military and civilian treatment facilities. The Compounding Center has received over $700,000 in prior awards from the Department of Health and Human Services...
This is a firm fixed price BPA call order awarded by the Defense Health Agency to Pharmakon Pharmaceutical, Inc., a woman-owned small business, for the provision of sterile compounds for the Walter Reed National Military Medical Center (WRNMMC). The total ceiling value of the contract is $983,313.32, with a period of performance through September 30, 2016. This contract does not have a set-aside designation. No further details about potential subcontractors or the agency's broader programs are...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded on June 9, 2021 by the Defense Health Agency to provide pharmaceutical supplies in support of agency programs. With a potential value of $25,000, the contract has a completion date of June 6, 2022 and calls off of an existing BPA for these products and services. The Compounding Center Inc. of Bethesda, Maryland will deliver the requested pharmaceutical supplies to locations within that city. No set-aside designation...
This is a firm fixed price contract awarded by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide specialized pharmaceutical compounds and medications to address shortages impacting patient care at military and civilian treatment facilities. The $650,000 contract is a blanket purchase agreement (BPA) call that allows for the expedited acquisition of customized drugs and...
The Defense Health Agency awarded a firm-fixed-price blanket purchase agreement (BPA) call worth $300,000.00 to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The contract is for the supply of shortage pharmaceuticals and blood products, as well as oncological pharmaceuticals and other relevant pharmaceutical products including injectables, orals, and medicinal inhalations. The Compounding Center will deliver these specialized medications and...
The Defense Health Agency awarded a firm fixed price contract to The Compounding Center Inc., a minority-owned and self-certified small disadvantaged business, to provide various shortage pharmaceutical items including blood products, oncological pharmaceuticals, injectables, orals, and inhalations. The $300,000.00 contract is a Blanket Purchase Agreement (BPA) Call with a performance period ending September 30, 2019. The Compounding Center, a for-profit Subchapter S corporation, has also...